Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2024, Vol. 29 ›› Issue (3): 328-333.doi: 10.12092/j.issn.1009-2501.2024.03.011

Previous Articles     Next Articles

Pharmacological characteristics of esketamine and its application progress in pediatric anesthesia

JIN Baowei1, GUO Jianrong2   

  1. 1 Department of Anesthesiology, Shaoxing People's Hospital, Shaoxing 312000, Zhejiang, China; 2 Department of Anesthesiology, Shanghai Gongli Hospital, Naval Military Medical  University, Shanghai 200135, China
  • Received:2023-09-18 Revised:2024-01-03 Online:2024-03-26 Published:2024-02-29

Abstract:

Esketamine is an antagonist of the N-methyl-D-aspartate (NMDA) receptor and exerts antianxiety, hypnotic, sedative, and analgesic effects by interacting with NMDA receptors, opioid receptors, M-choline receptors, monoamine receptors, adenosine receptors, and other purine receptors. As the more potents isomer of ketamine, it is about twice as potent as ketamine. Compared with ketamine, esketamine has the characteristics of rapid onset and metabolism, strong analgesia, slight respiratory depression, rapid recovery of cognitive function, and low incidence of psychiatric side effects. It has become a new choice of pediatric anesthesia drugs. This article reviews the pharmacological properties of esketamine and its recent application in pediatric anesthesia, and provides reference for the safe use of esketamine in pediatric perioperative period.

Key words: esketamine, sedative, analgesia, pediatric

CLC Number: